Paper Title:
TricOsTM and Fibrin Sealant Combined for Bone Defect Filling: from Pre-Clinical Tests to Prospective Clinical Study. Preliminary Human Data
  Abstract

The association of TricOsTM (Macroporous Biphasic Ceramic Phosphate MBCP granules) and the fibrin sealant FS VH S/D 4, has been developed to answer a challenging request of orthopaedic surgeons: a biocompatible, osteogenic, mouldable, and self-hardening bone substitute able to fill randomly shaped bone defects. The aims of this study was the evaluation of the performance and safety of the bioactive bone substitute TricOs™ associated with a fibrin sealant in regeneration of functional bone. The pre-clinical tests were conducted to optimize MBCP granules size and ratio MBCP–FS VH S/D 4 (sheep maxillary sinus grafting, femoral epiphysis defect in rabbits, long bone defects in sheep). A clinical study design was set up as an exploratory prospective French multicentric phase II study sponsored by INSERM (Institut National de la Santé et de la Recherche Médicale). The application was the TOV (Tibial Osteotomy of Valgisation) using osteosynthesis and bone substitute: TricOs™ mixed with the fibrin sealant (FS VH S/D 4) for filling the space created. The follow up is 13 months with safety checks, clinical assessments, highsensitivity X-ray, and CT-scan imaging. A bone sample will be collected from the reconstructed area at 12 months, during the osteosynthesis material removal surgery. The principal criterion is CT-scan imaging performed 12 months after TOV surgery, before material removal, to assess qualitative and quantitative bone reconstruction. Animals’ studies demonstrate that the biomaterial is safe to use and shows osteoconductive properties, granules resorption and bone ingrowth at the expenses of the implants. As for clinical trial, 7 patients are today included in the study: This paper present the first results obtained from X-ray imaging during follow up.

  Info
Periodical
Key Engineering Materials (Volumes 361-363)
Main Theme
Edited by
Guy Daculsi and Pierre Layrolle
Pages
1335-1338
DOI
10.4028/www.scientific.net/KEM.361-363.1335
Citation
M. Durand, D. Chauveaux, M. Moinard, T. Fabre, J. L. Rouvillain, M. Bagot d'Arc, G. Daculsi, "TricOsTM and Fibrin Sealant Combined for Bone Defect Filling: from Pre-Clinical Tests to Prospective Clinical Study. Preliminary Human Data", Key Engineering Materials, Vols. 361-363, pp. 1335-1338, 2008
Online since
November 2007
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: M. Gutierres, N. Sooraj Hussain, A. Afonso, L. Almeida, T. Cabral, M.A. Lopes, José D. Santos
Abstract:This paper reports the ability of Bonelike® to regenerate bone defected areas when implanted in the tibia of 3 patients (average age of 59...
1041
Authors: Clemencia Rodríguez, Alain Jean, Sylvia Mitja, G. Daculsi
Abstract:To overcome autograft use for dental implantation, it is important to prevent bone loss after tooth extraction or to restore alveolar bone...
1339
Authors: Franck Jegoux, Eric Goyenvalle, Eric Aguado, Ronan Cognet, Françoise Moreau, G. Daculsi
Abstract:The aim of this study was to evaluate the capacity of the association of calcium phosphate cement with collagen membrane for large segmental...
257
Authors: Marco A. Lopez-Heredia, Dirk Barnewitz, Antje Genzel, Michael Stiller, Fabian Peters, Wolf Dietrich Hübner, Benedikt Stang, Andrea Kuhr, Christine Knabe
XII. Preclinical Models: Animal Studies
Abstract:Calcium phosphates (CaPs) are synthetic bone grafting materials. CaPs are an alternative to overcome the drawbacks present with autologous...
426
Authors: Daculsi Guy, Thomas Miramond, Pascal Borget, Claire Morineau, Seris Elodie
Chapter 3: Materials and Technologies in Bone Implantation
Abstract:There are numerous clinical indications for bone grafts. The ideal graft material should favor bone apposition and growth while...
69